CYTOKINETICS INC
CYTK
92 insider filings · Latest: Oct 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Jul 27 8:33 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $80.87 | $606.5K | 377,820(D) | View → |
| Jul 21, 2026 | Jul 23 8:09 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $80.59 | $282.1K | 153,902(D) | View → |
| Jul 13, 2026 | Jul 14 7:34 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $82.02 | $615.1K | 377,820(D) | View → |
| Jul 7, 2026 | Jul 7 9:06 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $86.62 | $303.2K | 153,902(D) | View → |
| Jul 7, 2026 | Jul 7 8:35 PM | FADY MALIK | Proposed Sale | 24,500 | $85.57 | $2.1M | — | View → |
| Jul 1, 2026 | Jul 2 9:20 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $84.92 | $636.9K | 377,830(D) | View → |
| Jul 1, 2026 | Jul 2 9:19 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,000 | $85.80 | $1.3M | 58,555(D) | View → |
| Jul 1, 2026 | Jul 2 9:17 PM | Sung LeeEVP, Chief Financial Officer | Sale | 1,112 | $87.79 | $97.6K | 63,221(D) | View → |
| Jul 1, 2026 | Jul 1 8:54 PM | ROBERT BLUM | Proposed Sale | 52,500 | $85.19 | $4.5M | — | View → |
| Jun 24, 2026 | Jun 29 10:05 PM | Sung LeeEVP, Chief Financial Officer | Sale | 38,730 | $82.30 | $3.2M | 63,221(D) | View → |
| Jun 29, 2026 | Jun 29 9:23 PM | Sung LeeEVP, Chief Financial Officer | Sale | 3,134 | $85.00 | $266.4K | 63,221(D) | View → |
| Jun 29, 2026 | Jun 29 8:48 PM | Sung Lee | Proposed Sale | 9,503 | $82.19 | $781.1K | — | View → |
| Jun 26, 2026 | Jun 26 8:24 PM | Sung Lee | Proposed Sale | 6,695 | $80.80 | $541.0K | — | View → |
| Jun 24, 2026 | Jun 24 8:37 PM | Sung Lee | Proposed Sale | 38,730 | $80.01 | $3.1M | — | View → |
| Jun 23, 2026 | Jun 23 9:41 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $79.51 | $278.3K | 153,902(D) | View → |
| Jun 15, 2026 | Jun 15 8:40 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $70.46 | $528.5K | 385,330(D) | View → |
| Jun 9, 2026 | Jun 9 9:40 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $67.98 | $237.9K | 153,902(D) | View → |
| Jun 1, 2026 | Jun 1 10:54 PM | Edward M. Kaye MDDirector | Sale | 2,933 | $76.09 | $223.2K | 10,283(D) | View → |
| Jun 1, 2026 | Jun 1 10:51 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,000 | $74.08 | $1.1M | 58,555(D) | View → |
| Jun 1, 2026 | Jun 1 10:49 PM | Lynne B ParshallDirector | Sale | 5,000 | $74.08 | $370.4K | 15,784(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:11 PM | Robert I BlumDirector, President & CEO | Grant/Award | 113,529 | $60.06 | 111,864(D) | View → |
| Mar 15, 2026 | Mar 17 8:08 PM | Andrew CallosEVP, Chief Commercial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:06 PM | Jeffrey HessekielChief Legal & Admin Officer | Grant/Award | 31,145 | $60.06 | 22,820(D) | View → |
| Mar 15, 2026 | Mar 17 8:05 PM | Sung LeeEVP, Chief Financial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:03 PM | Fady Ibraham MalikEVP Research & Development | Grant/Award | 41,192 | $60.06 | 39,527(D) | View → |
| Mar 5, 2026 | Mar 5 9:27 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 26,000 | $39.13 | 69,000(D) | View → |
| Mar 2, 2026 | Mar 2 9:28 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 0(D) | View → |
| Feb 5, 2026 | Feb 6 1:17 AM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 84,000(D) | View → |
| Feb 2, 2026 | Feb 2 9:40 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 886(D) | View → |
← Previous
Page 3 of 3